Wordt geladen...
U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes
BACKGROUND: Changes in hemoglobin A1c (A1C), weight, and total daily insulin dose (TDD) were investigated following initiation of insulin U-500 (U500) alone or as part of a basal/bolus insulin (BBI) regimen. SUBJECTS AND METHODS: Records of patients with type 2 diabetes who were prescribed U500 were...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mary Ann Liebert, Inc.
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4088350/ https://ncbi.nlm.nih.gov/pubmed/22364143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2011.0248 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|